{"id":433,"date":"2001-11-01T17:11:01","date_gmt":"2001-11-01T09:11:01","guid":{"rendered":"http:\/\/optopharm.com.sg\/zh\/?p=433"},"modified":"2020-11-12T10:05:34","modified_gmt":"2020-11-12T02:05:34","slug":"solution-makers-solutions-to-slump","status":"publish","type":"post","link":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump","title":{"rendered":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.<\/p>\n","protected":false},"author":1,"featured_media":434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\n\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm<\/title>\n<meta name=\"description\" content=\"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm\" \/>\n<meta property=\"og:description\" content=\"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\" \/>\n<meta property=\"og:site_name\" content=\"Opto-Pharm\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/optopharm.sg\" \/>\n<meta property=\"article:published_time\" content=\"2001-11-01T09:11:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-12T02:05:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"optopharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"optopharm\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#article\",\"isPartOf\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\"},\"author\":{\"name\":\"optopharm\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc\"},\"headline\":\"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848\",\"datePublished\":\"2001-11-01T09:11:01+00:00\",\"dateModified\":\"2020-11-12T02:05:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\"},\"wordCount\":0,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage\"},\"thumbnailUrl\":\"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\",\"url\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\",\"name\":\"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm\",\"isPartOf\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage\"},\"image\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage\"},\"thumbnailUrl\":\"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg\",\"datePublished\":\"2001-11-01T09:11:01+00:00\",\"dateModified\":\"2020-11-12T02:05:34+00:00\",\"author\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc\"},\"description\":\"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.\",\"breadcrumb\":{\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage\",\"url\":\"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg\",\"contentUrl\":\"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg\",\"width\":600,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/optopharm.com.sg\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#website\",\"url\":\"https:\/\/optopharm.com.sg\/zh\/\",\"name\":\"Opto-Pharm\",\"description\":\"The leading pharmaceutical ophthalmic solutions manufacturer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/optopharm.com.sg\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc\",\"name\":\"optopharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2661d418c9d1cc608f102b1b9493dce9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2661d418c9d1cc608f102b1b9493dce9?s=96&d=mm&r=g\",\"caption\":\"optopharm\"},\"sameAs\":[\"http:\/\/optopharm.com.sg\/zh\",\"https:\/\/www.facebook.com\/optopharm.sg\",\"https:\/\/www.instagram.com\/optopharm.sg\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm","description":"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump","og_locale":"zh_TW","og_type":"article","og_title":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm","og_description":"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.","og_url":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump","og_site_name":"Opto-Pharm","article_author":"https:\/\/www.facebook.com\/optopharm.sg","article_published_time":"2001-11-01T09:11:01+00:00","article_modified_time":"2020-11-12T02:05:34+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg","type":"image\/jpeg"}],"author":"optopharm","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"optopharm"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#article","isPartOf":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump"},"author":{"name":"optopharm","@id":"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc"},"headline":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848","datePublished":"2001-11-01T09:11:01+00:00","dateModified":"2020-11-12T02:05:34+00:00","mainEntityOfPage":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump"},"wordCount":0,"commentCount":0,"image":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage"},"thumbnailUrl":"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg","articleSection":["Uncategorized"],"inLanguage":"zh-TW","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#respond"]}]},{"@type":"WebPage","@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump","url":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump","name":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848 - Opto-Pharm","isPartOf":{"@id":"https:\/\/optopharm.com.sg\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage"},"image":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage"},"thumbnailUrl":"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg","datePublished":"2001-11-01T09:11:01+00:00","dateModified":"2020-11-12T02:05:34+00:00","author":{"@id":"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc"},"description":"Despite dip in sales, contact-lens solution maker, held up as model of a successful SME, pumped money into new products and research.","breadcrumb":{"@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#primaryimage","url":"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg","contentUrl":"https:\/\/optopharm.com.sg\/zh\/wp-content\/uploads\/2020\/08\/news006.jpg","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/optopharm.com.sg\/zh\/solution-makers-solutions-to-slump#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/optopharm.com.sg\/zh\/"},{"@type":"ListItem","position":2,"name":"\u62a4\u7406\u6db2\u5236\u9020\u5546\u5e94\u5bf9\u7ecf\u6d4e\u8427\u6761\u65b9\u6848"}]},{"@type":"WebSite","@id":"https:\/\/optopharm.com.sg\/zh\/#website","url":"https:\/\/optopharm.com.sg\/zh\/","name":"Opto-Pharm","description":"The leading pharmaceutical ophthalmic solutions manufacturer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/optopharm.com.sg\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Person","@id":"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/558f8680e46159337349268200961dbc","name":"optopharm","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/optopharm.com.sg\/zh\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2661d418c9d1cc608f102b1b9493dce9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2661d418c9d1cc608f102b1b9493dce9?s=96&d=mm&r=g","caption":"optopharm"},"sameAs":["http:\/\/optopharm.com.sg\/zh","https:\/\/www.facebook.com\/optopharm.sg","https:\/\/www.instagram.com\/optopharm.sg"]}]}},"_links":{"self":[{"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/posts\/433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/comments?post=433"}],"version-history":[{"count":5,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/posts\/433\/revisions"}],"predecessor-version":[{"id":529,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/posts\/433\/revisions\/529"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/media\/434"}],"wp:attachment":[{"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/media?parent=433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/categories?post=433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/optopharm.com.sg\/zh\/wp-json\/wp\/v2\/tags?post=433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}